Introduction Semaglutide Has emerged as a groundbreaking medication in the treatment of type 2 diabetes and obesity, with its ability to address multiple health issues through a single solution. Initially developed as a therapy for diabetes, Semaglutide belongs to the GLP-1 (glucagon-like peptide-1) receptor agonists, a class of drugs that https://johnathanflrwb.blogstival.com/53649511/semaglutide-a-breakthrough-treatment-for-diabetes-weight-loss-and-cardiovascular-health